One of the options for treatment your oncologist may recommend is for you to participate in a clinical trial. Clinical trials are carefully designed research studies that answer specific questions regarding the effectiveness and safety of new drugs, combinations of drugs, treatments, surgical techniques, or medical devices. Human volunteers with specific health conditions are studied [...]
From a unknown source: "Watch out! You nearly broad sided that car!" My father yelled at me. "Can't you do anything right?" Those words hurt worse than blows. I turned my head toward the elderly man in the seat beside me, daring me to challenge him. A lump rose in my throat as I averted [...]
Susan G. Komen for the Cure CEO Hala Moddelmog testified before a special hearing of the Senate Committee on Health, Education, Labor and Pensions on the need for comprehensive legislation to address the nation's cancer crisis. Along with Moddeling at the committee meeting was Elizabeth Edwards and Lance Armstrong. Moddeling, in her testimony, emphasized the [...]
Prostate cancer preferentially metastasizes to bone and the mortality from prostate cancer is 70% once bone metastases are present. In addition, prostate cancer-induced bone metastases are associated with significant complications including severe pain, skeletal fractures, spinal cord compression and bone marrow suppression. Most doctors structure their treatment protocols against bone metastases by treating the cancer [...]
Watson Pharmaceuticals, Inc. (WPI), announced that the U.S. Food and Drug Administration (FDA) has approved MIXJECT, which is a new delivery system for TRELSTAR (triptorelin pamoate for injectable suspension). The delivery system includes some new features, a smaller 21-gauge needle that should improve comfort and a shield covering the needle both before and after drug [...]